Wegovy was also approved for weight management by the FDA in June 2021
It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating insulin release, inhibiting glucagon release, and slowing gastric emptying
Starting with walking, swimming, or low-impact strength training and gradually increasing intensity allows your body to adapt safely while maximizing the metabolic benefits of your medication
Still, in practice, especially with GLP-1 medicines like Tirzepatide (Mounjaro, Zepbound), patients sometimes report feeling off
However, if the infection is severe, they might advise stopping semaglutide temporarily
[2] [3] While semaglutide offers significant therapeutic benefits for diabetes management and weight reduction, recognizing and managing its gastrointestinal side effects remains an important aspect of treatment optimization